PTC Therapeutics (PTCT) PT Lowered to $53 at JPMorgan, 'Late Stage Assets Remain Significantly Underappreciated'

Go back to PTC Therapeutics (PTCT) PT Lowered to $53 at JPMorgan, 'Late Stage Assets Remain Significantly Underappreciated'

Form 8-K PTC THERAPEUTICS, INC. For: Sep 15

September 15, 2023 6:20 AM EDT

... More